AMP Therapeutics Overview

  • Founded
  • 2009
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 3
Employees
  • Latest Deal Type
  • M&A

AMP Therapeutics General Information

Description

Operator of a pharmaceutical company developing anti-microbial peptides. The company focuses on the discovery and development of antibiotics for the treatment of multi drug-resistant Gram-negative infections.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • Deutscher Platz 5c
  • 04103 Leipzig
  • Germany
+49 0341 00000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AMP Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 03-Nov-2016 Completed Generating Revenue
2. Grant 25-Oct-2012 00.00 Completed Startup
1. Early Stage VC (Series A) 05-Jan-2012 Completed Startup
To view AMP Therapeutics’s complete valuation and funding history, request access »

AMP Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Jörg Gabert Co-Founder, Vice Chairman of the Advisory Board and Managing Director
Marc Hentz Managing Director, Finance and Business Development
Knut Adermann Scientific Director
Ralf Hoffmann Ph.D Co-Founder (Scienific)
Bernrd Eisele Advisor
To view AMP Therapeutics’s complete executive team members history, request access »

AMP Therapeutics Board Members (3)

Name Representing Role Since
Jörg Gabert AMP Therapeutics Co-Founder, Vice Chairman of the Advisory Board and Managing Director 000 0000
To view AMP Therapeutics’s complete board members history, request access »

AMP Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AMP Therapeutics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Boehringer Ingelheim Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
Bundesministerium für Bildung und Forschung Government 000 0000 000000 0
Novartis Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
To view AMP Therapeutics’s complete investors history, request access »